High prevalence of Chlamydia pneumoniae antibodies in white-coat hypertensives
- 1 April 2003
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 167 (2) , 231-235
- https://doi.org/10.1016/s0021-9150(02)00426-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Essential hypertension is associated with Chlamydia pneumoniae but not Epstein-Barr antibodiesAmerican Journal of Hypertension, 2002
- Properly defining white coat hypertensionPublished by Oxford University Press (OUP) ,2002
- Chlamydia pneumoniae Antibodies in Severe Essential HypertensionHypertension, 1998
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of internal medicine (1960), 1997
- Is white-coat hypertension innocent?The Lancet, 1996
- Parallel cardiac and vascular adaptation in hypertension.Circulation, 1992
- "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan.Hypertension, 1990
- What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients?Hypertension, 1985
- Normotension and hypertension: The mysterious viability of the falseThe American Journal of Medicine, 1978
- BLOOD PRESSURE DETERMINATIONS BY PATIENTS WITH ESSENTIAL HYPERTENSIONThe Lancet Healthy Longevity, 1940